Addex Therapeutics Ltd ADXN.SW Stock
Addex Therapeutics Ltd Price Chart
Addex Therapeutics Ltd ADXN.SW Financial and Trading Overview
| Addex Therapeutics Ltd stock price | 0.19 CHF |
| Previous Close | 0.11 CHF |
| Open | 0.12 CHF |
| Bid | 0 CHF x 0 |
| Ask | 0.11 CHF x 0 |
| Day's Range | 0.11 - 0.12 CHF |
| 52 Week Range | 0.1 - 0.5 CHF |
| Volume | 166.9K CHF |
| Avg. Volume | 310.56K CHF |
| Market Cap | 9.77M CHF |
| Beta (5Y Monthly) | 1.677777 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.15 CHF |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ADXN.SW Valuation Measures
| Enterprise Value | 1.64M CHF |
| Trailing P/E | N/A |
| Forward P/E | -0.7333333 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.7382975 |
| Price/Book (mrq) | 1.7187499 |
| Enterprise Value/Revenue | 0.964 |
| Enterprise Value/EBITDA | -0.095 |
Trading Information
Addex Therapeutics Ltd Stock Price History
| Beta (5Y Monthly) | 1.677777 |
| 52-Week Change | -60.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.5 CHF |
| 52 Week Low | 0.1 CHF |
| 50-Day Moving Average | 0.13 CHF |
| 200-Day Moving Average | 0.16 CHF |
ADXN.SW Share Statistics
| Avg. Volume (3 month) | 310.56K CHF |
| Avg. Daily Volume (10-Days) | 146.67K CHF |
| Shares Outstanding | 88.84M |
| Float | 22.41M |
| Short Ratio | N/A |
| % Held by Insiders | 8.87% |
| % Held by Institutions | 9.27% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1007.43% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -85.86% |
| Return on Equity (ttm) | -204.24% |
Income Statement
| Revenue (ttm) | 1.7M CHF |
| Revenue Per Share (ttm) | 0.03 CHF |
| Quarterly Revenue Growth (yoy) | 105.80% |
| Gross Profit (ttm) | 1.44M CHF |
| EBITDA | -17205740 CHF |
| Net Income Avi to Common (ttm) | -17387648 CHF |
| Diluted EPS (ttm) | -0.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.59M CHF |
| Total Cash Per Share (mrq) | 0.09 CHF |
| Total Debt (mrq) | 259.12K CHF |
| Total Debt/Equity (mrq) | 6.37 CHF |
| Current Ratio (mrq) | 2.17 |
| Book Value Per Share (mrq) | 0.064 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13951998 CHF |
| Levered Free Cash Flow (ttm) | -7522928 CHF |
Profile of Addex Therapeutics Ltd
| Country | Switzerland |
| State | N/A |
| City | Geneva |
| Address | Chemin des Mines, 9 |
| ZIP | 1202 |
| Phone | 41 22 884 1555 |
| Website | https://www.addextherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 24 |
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for pain, anxiety, and addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.
Q&A For Addex Therapeutics Ltd Stock
What is a current ADXN.SW stock price?
Addex Therapeutics Ltd ADXN.SW stock price today per share is 0.19 CHF.
How to purchase Addex Therapeutics Ltd stock?
You can buy ADXN.SW shares on the Swiss exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Addex Therapeutics Ltd?
The stock symbol or ticker of Addex Therapeutics Ltd is ADXN.SW.
Which industry does the Addex Therapeutics Ltd company belong to?
The Addex Therapeutics Ltd industry is Biotechnology.
How many shares does Addex Therapeutics Ltd have in circulation?
The max supply of Addex Therapeutics Ltd shares is 127.15M.
What is Addex Therapeutics Ltd Price to Earnings Ratio (PE Ratio)?
Addex Therapeutics Ltd PE Ratio is now.
What was Addex Therapeutics Ltd earnings per share over the trailing 12 months (TTM)?
Addex Therapeutics Ltd EPS is -0.15 CHF over the trailing 12 months.
Which sector does the Addex Therapeutics Ltd company belong to?
The Addex Therapeutics Ltd sector is Healthcare.
Addex Therapeutics Ltd ADXN.SW included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| SPI TR SSHI | 15051.28 CHF 17125.13 USD |
-0.5
|
— — | 15030.9 CHF 17101.95 USD | 15256.93 CHF 17359.12 USD | — - | — — |
- {{ link.label }} {{link}}